IGLV8-61
Immunoglobulin lambda variable 8-61
Also known as: LV861_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A075B6I0
- Gene
- IGLV8-61
- Ensembl
- ENSG00000211638
- Chromosome
- 22
- Canonical length
- 122 aa
- Protein class
- Immunoglobulin genes, Predicted secreted proteins
- Secretome location
- Immunoglobulin genes
OverviewNCBI Gene
Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
122 residues, UniProt reviewed canonical sequence.
>A0A075B6I0|IGLV8-61
1 MSVPTMAWMM LLLGLLAYGS GVDSQTVVTQ EPSFSVSPGG TVTLTCGLSS GSVSTSYYPS
61 WYQQTPGQAP RTLIYSTNTR SSGVPDRFSG SILGNKAALT ITGAQADDES DYYCVLYMGS
121 GILocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGLV8-61 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 916 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 916 nTPM
- duodenum: 756 nTPM
- spleen: 255 nTPM
- lymph node: 241 nTPM
- urinary bladder: 232 nTPM
- colon: 187 nTPM
Single-cell type
- plasma cells: 13 nCPM
- foveolar cells: 1.5 nCPM
- cholangiocytes: 1.3 nCPM
- gastric chief cells: 1.1 nCPM
- kupffer cells: 1 nCPM
- melanocytes: 0.4 nCPM
Immune cell
- naive B-cell: 534 nTPM
- memory B-cell: 259 nTPM
- total PBMC: 33 nTPM
- classical monocyte: 0.6 nTPM
- myeloid DC: 0.4 nTPM
- non-classical monocyte: 0.4 nTPM
Brain region
- cerebral cortex: 3.3 nTPM
- choroid plexus: 1.7 nTPM
- white matter: 1.6 nTPM
- pons: 1.3 nTPM
- spinal cord: 1.3 nTPM
- medulla oblongata: 0.4 nTPM
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGLV8-61 as an antibody target. Whether an autoantibody or antibody against IGLV8-61 could matter depends on whether native IGLV8-61 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGLV8-61 is annotated at the cell surface, where native IGLV8-61 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGLV8-61 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...